XML 31 R16.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Balance Sheet Components | 12 Months Ended
--- | ---
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Balance Sheet Components | BALANCE SHEET COMPONENTS Inventory Inventory consisted of the following (in thousands):
| December 31,
| 2024 |  | 2023
Finished goods | $ | 4,819 |  |  | $ | 3,658 |
Work in progress | 3,793 |  |  | 5,191 |
Raw materials | 10,891 |  |  | 10,622 |
Total inventory | $ | 19,503 |  |  | $ | 19,471 |
Property and Equipment, Net Property and equipment consisted of the following (in thousands):
| December 31,
| 2024 |  | 2023
Machinery and equipment | $ | 18,771 |  |  | $ | 18,051 |
Leasehold improvements | 18,106 |  |  | 18,259 |
Internally developed software | 13,843 |  |  | 15,116 |
Construction in progress | 11,937 |  |  | 8,306 |
Computer and office equipment | 5,650 |  |  | 5,609 |
Furniture and fixtures | 2,187 |  |  | 2,168 |
Property and equipment | 70,494 |  |  | 67,509 |
Less: Accumulated depreciation and amortization | (36,942) |  |  | (32,263) |
Property and equipment, net | $ | 33,552 |  |  | $ | 35,246 |
Depreciation expense was $7.8 million, $7.9 million and $5.2 million for the years ended December 31, 2024, 2023 and 2022, respectively. Accrued and Other Liabilities Accrued and other liabilities consisted of the following (in thousands):
| December 31,
| 2024 |  | 2023
Clinical studies | $ | 16,166 |  |  | $ | 15,744 |
Short-term lease liability | 6,103 |  |  | 5,943 |
Professional fees | 5,971 |  |  | 5,911 |
Deferred revenue | 4,848 |  |  | 4,748 |
Laboratory processing fees and materials | 3,184 |  |  | 2,890 |
Contingent consideration | 2,414 |  |  | 5,469 |
Travel and expenses | 819 |  |  | — |
Accrued shipping expenses | 504 |  |  | 335 |
Accrued royalty | 255 |  |  | 348 |
Deferred payments for intangible assets | 250 |  |  | 920 |
Capital expenditures | 126 |  |  | 151 |
License and other collaboration fees | 67 |  |  | 250 |
Other accrued expenses | 2,645 |  |  | 2,788 |
Total accrued and other liabilities | $ | 43,352 |  |  | $ | 45,497 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration